FDA
-
-
-
-
-
-
-
Abiomed (ABMD) Announces FDA Approval of Impella RP Flex with SmartAssist
-
-
-
-
-
-
-
Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support
-
-
-
-
-
-
-
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)
-
-
-
-
-
-
-
World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump
-
-
-
-
-
-
-
Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes
-
-
-
-
-
-
-
Abiomed (ABMD) Right Heart Failure Pump Gains FDA Pre-Market Approval
-
-
-
-
-
-
-
Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

